3D Bioprinting

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

3D Printed Breast implants consisting of 200cc in volume of CollPlant's rhCollagen-based bioinks produced on a Stratasys' Origin® printer to…

3 months ago

Society of Rheology Announces Winners of the 2024 Journal of Rheology Publication Award

Four researchers from the Karlsruhe Institute of Technology are recognized for developing an innovative strategy to analyze and formulate complex fluids…

4 months ago

3D Cell Culture Market to Transcend USD 11.79 Billion Valuation by 2031, Rising Demand for Regenerative Medicine to Augment Market Development | SkyQuest Technology

WESTFORD, Mass., July 12, 2024 /PRNewswire/ -- According to SkyQuest, the global 3D Cell Culture Market size was valued at USD…

4 months ago

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates

SAN DIEGO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology (3D biology) company focused…

2 years ago

Meeting The Challenges Of Bioprinting

3D bioprinting offers opportunities such as testing treatment for diseases using artificially affected tissues, and through using bioink, it’s much…

5 years ago